专利名称:Use of L-Histidine and derivatives thereof发明人:Baranyai Zsolt,Ernö Brücher,Simona
Bussi,Alessandro Maiocchi,Fulvio Uggeri
申请号:US14235128申请日:20120724公开号:US09012483B2公开日:20150421
摘要:The present invention discloses the use of L-Histidine to reduce Gadoliniumaccumulation into target organs, preventing its toxic effects, after administration ofgadolinium based contrast agents. The invention thus, also disclose the use of L-Histidineto prevent the NSF syndrome in patients with renal functionality impairment. A kit of partis also disclosed by the use of which toxicity associated to free Gd3+, deriving fromGDBCA, is prevented by oral administration of L-histidine before administration of thecontrast agent. A method for the prevention of toxic metal accumulation which consists inthe administration, preferably by the oral route, of L-Histidine is also disclosed. L-Histidine is preferably administered as a single oral dose comprised from 0.2-20 g.
申请人:Baranyai Zsolt,Ernö Brücher,Simona Bussi,Alessandro Maiocchi,Fulvio Uggeri
地址:Debrecen HU,Debrecen HU,Vercelli IT,Monza IT,Codogno IT
国籍:HU,HU,IT,IT,IT
代理人:M. Caragh Noone
更多信息请下载全文后查看
因篇幅问题不能全部显示,请点此查看更多更全内容